Williamson et al., 2006 - Google Patents
PCL–PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cellsWilliamson et al., 2006
- Document ID
- 11887960972490833181
- Author
- Williamson M
- Black R
- Kielty C
- Publication year
- Publication venue
- Biomaterials
External Links
Snippet
A new compliant scaffold suitable for small-diameter vascular grafts has been developed that promotes strong attachment of endothelial cells. Composite scaffolds were produced by wet spinning polycaprolactone (PCL) fibres which form the luminal surface, then …
- 239000002131 composite material 0 title abstract description 48
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Williamson et al. | PCL–PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells | |
Melchiorri et al. | In vitro endothelialization of biodegradable vascular grafts via endothelial progenitor cell seeding and maturation in a tubular perfusion system bioreactor | |
Pennings et al. | Layer-specific cell differentiation in bi-layered vascular grafts under flow perfusion | |
Feugier et al. | Attachment, morphology and adherence of human endothelial cells to vascular prosthesis materials under the action of shear stress | |
Santos et al. | Response of micro-and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering | |
Hoerstrup et al. | Tissue engineering of small caliber vascular grafts | |
Whited et al. | The influence of electrospun scaffold topography on endothelial cell morphology, alignment, and adhesion in response to fluid flow | |
Sreerekha et al. | Cultivation of endothelial progenitor cells on fibrin matrix and layering on dacron/polytetrafluoroethylene vascular grafts | |
Chu et al. | Enhanced growth of animal and human endothelial cells on biodegradable polymers | |
Zhou et al. | Tissue engineering of small‐diameter vascular grafts by endothelial progenitor cells seeding heparin‐coated decellularized scaffolds | |
Williamson et al. | The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment | |
Sgarioto et al. | Collagen type I together with fibronectin provide a better support for endothelialization | |
Moreno et al. | Development of a compliant and cytocompatible micro‐fibrous polyethylene terephthalate vascular scaffold | |
Gholobova et al. | Functional evaluation of prevascularization in one-stage versus two-stage tissue engineering approach of human bio-artificial muscle | |
Arrigoni et al. | Rotating versus perfusion bioreactor for the culture of engineered vascular constructs based on hyaluronic acid | |
Suuronen et al. | Building in vitro models of organs | |
Anderson et al. | Perspectives on the inflammatory, healing, and foreign body responses to biomaterials and medical devices | |
Merzkirch et al. | Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides? | |
Huynh et al. | Fusion of concentrically layered tubular tissue constructs increases burst strength | |
Klopsch et al. | Spray‐and laser‐assisted biomaterial processing for fast and efficient autologous cell‐plus‐matrix tissue engineering | |
Saito et al. | Scaffold‐free tissue‐engineered arterial grafts derived from human skeletal myoblasts | |
Sun et al. | Construction of spider silk protein small‐caliber tissue engineering vascular grafts based on dynamic culture and its performance evaluation | |
S Vara et al. | Haemodynamic regulation of gene expression in vascular tissue engineering | |
Bär et al. | The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro | |
Aper et al. | Development of implantable autologous small-calibre vascular grafts from peripheral blood samples |